Xenetic Biosciences, Inc. (XBIO)
4.20
-0.08
(-1.87%)
USD |
NASDAQ |
Sep 09, 15:01
Xenetic Biosciences Market Cap : 9.841M for Sept. 9, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 10.03M |
| September 04, 2026 | 10.94M |
| September 03, 2026 | 10.85M |
| September 02, 2026 | 9.959M |
| September 01, 2026 | 9.912M |
| August 31, 2026 | 9.818M |
| August 28, 2026 | 9.326M |
| August 27, 2026 | 9.302M |
| August 26, 2026 | 9.045M |
| August 25, 2026 | 8.951M |
| August 24, 2026 | 8.928M |
| August 21, 2026 | 8.412M |
| August 20, 2026 | 7.943M |
| August 19, 2026 | 7.873M |
| August 18, 2026 | 7.615M |
| August 17, 2026 | 7.639M |
| August 14, 2026 | 7.686M |
| August 13, 2026 | 7.709M |
| August 12, 2026 | 7.733M |
| August 11, 2026 | 7.545M |
| August 10, 2026 | 7.240M |
| August 07, 2026 | 7.428M |
| August 06, 2026 | 6.678M |
| August 05, 2026 | 6.936M |
| August 04, 2026 | 6.584M |
| Date | Value |
|---|---|
| August 03, 2026 | 6.094M |
| July 31, 2026 | 5.808M |
| July 30, 2026 | 5.842M |
| July 29, 2026 | 5.682M |
| July 28, 2026 | 5.728M |
| July 27, 2026 | 5.728M |
| July 24, 2026 | 6.048M |
| July 23, 2026 | 6.152M |
| July 22, 2026 | 6.117M |
| July 21, 2026 | 6.186M |
| July 20, 2026 | 6.438M |
| July 17, 2026 | 6.374M |
| July 16, 2026 | 6.438M |
| July 15, 2026 | 6.644M |
| July 14, 2026 | 6.873M |
| July 13, 2026 | 6.461M |
| July 10, 2026 | 6.266M |
| July 09, 2026 | 6.358M |
| July 08, 2026 | 6.209M |
| July 07, 2026 | 6.621M |
| July 06, 2026 | 6.530M |
| July 02, 2026 | 6.346M |
| July 01, 2026 | 6.736M |
| June 30, 2026 | 6.667M |
| June 29, 2026 | 6.530M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 11.75B |
| Oncolytics Biotech, Inc. | 100.16M |
| Sangamo Therapeutics, Inc. | 66.66M |
| Sarepta Therapeutics, Inc. | 2.341B |
| Anixa Biosciences, Inc. | 96.51M |
Market Cap Related Metrics
| PS Ratio | 2.711 |
| Price to Book Value | 1.621 |
| Price | 4.20 |
| Earnings Yield | -28.28% |